Tech Company Financing Transactions
Exostar Funding Round
Exostar, operating out of Herndon, scored $10 million from Merck Global Health Innovation Fund.
Transaction Overview
Company Name
Announced On
10/28/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Merck GHI's investment will allow Exostar to enhance and expand its HIPAA-compliant solutions that help pharmaceutical companies, healthcare providers, and others in the industry securely, productively, and compliantly collaborate with one another to develop new drugs and therapies and deliver the best possible patient care.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
2325 Dulles Corner Blvd. 600
Herndon, VA 20171
USA
Herndon, VA 20171
USA
Phone
Website
Email Address
Overview
Secure cloud platforms to share ideas, develop solutions & improve productivity. Owned by Boeing, Rolls Royce, Lockheed Martin, BAE Systems, Raytheon & Merck.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Addi
Chief Financial Officer
Patrick Kannan
Chief Information Officer
Waide Jones
VP - Bus. Development
Sean O'Neill
VP - Human Resources
Venencia Magnusen
VP - Operations
Eric Sorensen
VP - Product Management
Vijay Takanti
Browse more venture capital transactions:
Prev: 10/28/2015: Zype venture capital transaction
Next: 10/28/2015: Sportradar venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs